Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
HeartWare wins premarket approval for its flagship implantable left ventricular assist device as a bridge to transplant for heart failure patients.
Medtronic executives detail the $245 million hit from a legal loss to Edwards Lifesciences, saying the decision won’t have an impact on the timeline for launching its CoreValve heart implant.
St. Jude Medical shares are down 11% today after the FDA releases a report slamming the company over its Durata pacemaker leads.